 |
|||||||||||
|
| Presenting Company | Webcasting Link |
| ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) | http://www.wsw.com/webcast/rrshq22/acad |
| AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) | http://www.wsw.com/webcast/rrshq22/acrx |
| Active Biotech AB (OME: ACTI SS) | http://www.wsw.com/webcast/rrshq22/acti.ss |
| Adherex Technologies, Inc. (TSX: AHX CN) | http://wsw.com/webcast/rrshq22/ahx.cn |
| ADMA Biologics, Inc. | http://www.wsw.com/webcast/rrshq22/adma |
| Advanced Cell Technology, Inc. (OTC BB: ACTC) | http://wsw.com/webcast/rrshq22/actc |
| Advaxis, Inc. (OTC BB: ADXS) | http://www.wsw.com/webcast/rrshq22/adxs |
| ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) | http://wsw.com/webcast/rrshq22/anx |
| Aeterna Zentaris Inc. (NASDAQ: AEZS) | http://www.wsw.com/webcast/rrshq22/aezs |
| Affymax, Inc. (NASDAQ: AFFY) | http://www.wsw.com/webcast/rrshq22/affy |
| Agenus Inc. (NASDAQ: AGEN) | http://www.wsw.com/webcast/rrshq22/agen |
| Albany Molecular Research, Inc. (NASDAQ: AMRI) | http://www.wsw.com/webcast/rrshq22/amri |
| Allon Therapeutics, Inc. (TSX: NPC CN) | http://www.wsw.com/webcast/rrshq22/npc.cn |
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | http://www.wsw.com/webcast/rrshq22/alny |
| ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) | http://wsw.com/webcast/rrshq22/aria |
| Arrowhead Research Corporation (NASDAQ: ARWR) | http://wsw.com/webcast/rrshq22/arwr |
| AspenBio Pharma, Inc. (NASDAQ: APPY) | http://www.wsw.com/webcast/rrshq22/appy |
| Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) | http://www.wsw.com/webcast/rrshq22/astx |
| Bio-Path Holdings, Inc. (OTC BB: BPTH) | http://www.wsw.com/webcast/rrshq22/bpth |
| BIOLASE, Inc. (NASDAQ: BIOL) | http://www.wsw.com/webcast/rrshq22/biol |
| BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) | http://www.wsw.com/webcast/rrshq22/bpax |
| Biospecifics Technologies Corp. (NASDAQ: BSTC) | http://www.wsw.com/webcast/rrshq22/bstc |
| Cardium Therapeutics, Inc. (NYSE MKT: CXM) | http://www.wsw.com/webcast/rrshq22/cxm |
| Cell Source Ltd. | http://www.wsw.com/webcast/rrshq22/clls |
| Cell Therapeutics, Inc. (NASDAQ: CTIC) | http://www.wsw.com/webcast/rrshq22/ctic |
| Cellceutix Corporation (OTC BB: CTIX) | http://www.wsw.com/webcast/rrshq22/ctix |
| Celsion Corporation (NASDAQ: CLSN) | http://www.wsw.com/webcast/rrshq22/clsn |
| Champions Oncology, Inc. (OTC US: CSBR) | http://www.wsw.com/webcast/rrshq22/csbr |
| Cleveland Biolabs, Inc. (NASDAQ: CBLI) | http://www.wsw.com/webcast/rrshq22/cbli |
| Cortex Pharmaceuticals, Inc. (OTC BB: CORX) | http://www.wsw.com/webcast/rrshq22/corx |
| Curis, Inc. (NASDAQ: CRIS) | http://www.wsw.com/webcast/rrshq22/cris |
| Cynosure, Inc. (NASDAQ: CYNO) | http://www.wsw.com/webcast/rrshq22/cyno |
| Cytokinetics, Incorporated (NASDAQ: CYTK) | http://wsw.com/webcast/rrshq22/cytk |
| Cytosorbents Corporation (OTC BB: CTSO) | http://www.wsw.com/webcast/rrshq22/ctso |
| CytRx Corporation (NASDAQ: CYTR) | http://www.wsw.com/webcast/rrshq22/cytr |
| Dendreon Corporation (NASDAQ: DNDN) | http://www.wsw.com/webcast/rrshq22/dndn |
| Derma Sciences, Inc. (NASDAQ: DSCI) | http://www.wsw.com/webcast/rrshq22/dsci |
| DURECT Corporation (NASDAQ: DRRX) | http://www.wsw.com/webcast/rrshq22/drrx |
| DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) | http://www.wsw.com/webcast/rrshq22/dusa |
| Dyax Corp. (NASDAQ: DYAX) | http://www.wsw.com/webcast/rrshq22/dyax |
| Echo Therapeutics, Inc. (NASDAQ: ECTE) | http://www.wsw.com/webcast/rrshq22/ecte |
| Endocyte, Inc. (NASDAQ: ECYT) | http://www.wsw.com/webcast/rrshq22/ecyt |
| Fluoropharma, Inc. (OTC BB: FPMI) | http://www.wsw.com/webcast/rrshq22/fpmi |
| Galena Biopharma, Inc. (NASDAQ: GALE) | http://www.wsw.com/webcast/rrshq22/gale |
| Geron Corporation (NASDAQ: GERN) | http://www.wsw.com/webcast/rrshq22/gern |
| Hemispherx Biopharma, Inc. (NYSE MKT: HEB) | http://wsw.com/webcast/rrshq22/heb |
| Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) | http://www.wsw.com/webcast/rrshq22/idra |
| ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) | http://www.wsw.com/webcast/rrshq22/imuc |
| Immunovaccine Inc. (TSX: IMV CN) | http://www.wsw.com/webcast/rrshq22/imv.v |
| Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) | http://www.wsw.com/webcast/rrshq22/infi |
| InVivo Therapeutics Holdings Corp. (OTC BB: NVIV) | http://www.wsw.com/webcast/rrshq22/nviv |
| Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) | http://www.wsw.com/webcast/rrshq22/isis |
| Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) | http://www.wsw.com/webcast/rrshq22/kerx |
| MannKind Corporation (NASDAQ: MNKD) | http://www.wsw.com/webcast/rrshq22/mnkd |
| MediciNova, Inc. (NASDAQ: MNOV) | http://www.wsw.com/webcast/rrshq22/mnov |
| Medivir AB (OME: MVIRB SS) | http://www.wsw.com/webcast/rrshq22/mvirb |
| MRI Interventions, Inc. (OTC BB: MRIC) | http://www.wsw.com/webcast/rrshq22/mric |
| Nanosphere, Inc. (NASDAQ: NSPH) | http://www.wsw.com/webcast/rrshq22/nsph |
| Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) | http://wsw.com/webcast/rrshq22/navb |
| NeoStem, Inc. (NYSE MKT: NBS) | http://wsw.com/webcast/rrshq22/nbs |
| Neuralstem, Inc. (NYSE MKT: CUR) | http://wsw.com/webcast/rrshq22/cur |
| Novelos Therapeutics, Inc. (OTC BB: NVLT) | http://www.wsw.com/webcast/rrshq22/nvlt |
| Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) | http://www.wsw.com/webcast/rrshq22/ocls |
| OHR Pharmaceutical, Inc. (OTC BB: OHRP) | http://www.wsw.com/webcast/rrshq22/ohrp |
| OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) | http://www.wsw.com/webcast/rrshq22/ogxi |
| OncoSec Medical Incorporated (OTC BB: ONCS) | http://www.wsw.com/webcast/rrshq22/oncs |
| Oncothyreon Inc. (NASDAQ: ONTY) | http://www.wsw.com/webcast/rrshq22/onty |
| Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) | http://www.wsw.com/webcast/rrshq22/onxx |
| Orexigen Therapeutics, Inc. (NASDAQ: OREX) | http://www.wsw.com/webcast/rrshq22/orex |
| PDL BioPharma, Inc. (NASDAQ: PDLI) | http://www.wsw.com/webcast/rrshq22/pdli |
| PolyMedix, Inc. (OTC BB: PYMX) | http://www.wsw.com/webcast/rrshq22/pymx |
| Provectus Pharmaceuticals, Inc. (OTC BB: PVCT) | http://www.wsw.com/webcast/rrshq22/pvct |
| pSivida Corp. (NASDAQ: PSDV) | http://www.wsw.com/webcast/rrshq22/psdv |
| RepliCel Life Sciences Inc. (OTC BB: REPCF) | http://www.wsw.com/webcast/rrshq22/repcf |
| Resverlogix Corp. (TSX: RVX CN) | http://www.wsw.com/webcast/rrshq22/rvx.cn |
| Safeguard Scientifics, Inc. (NYSE MKT: SFE) | http://www.wsw.com/webcast/rrshq22/sfe |
| Sarepta Therapeutics, Inc. (NASDAQ: SRPT) | http://www.wsw.com/webcast/rrshq22/srpt |
| Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) | http://wsw.com/webcast/rrshq22/svnt |
| SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) | http://www.wsw.com/webcast/rrshq22/scln |
| Senesco Technologies, Inc. (NYSE MKT: SNT) | http://www.wsw.com/webcast/rrshq22/snt |
| Spectral Diagnostics Inc. (TSX: SDI CN) | http://www.wsw.com/webcast/rrshq22/sdi.to |
| SpectraScience, Inc. (OTC BB: SCIE) | http://www.wsw.com/webcast/rrshq22/scie |
| Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) | http://www.wsw.com/webcast/rrshq22/sppi |
| Spherix Incorporated (NASDAQ: SPEX) | http://www.wsw.com/webcast/rrshq22/spex |
| Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) | http://www.wsw.com/webcast/rrshq22/scmp |
| Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) | http://wsw.com/webcast/rrshq22/supn |
| Synta Pharmaceuticals Corp. (NASDAQ: SNTA) | http://www.wsw.com/webcast/rrshq22/snta |
| Tengion, Inc. (NASDAQ: TNGN) | http://www.wsw.com/webcast/rrshq22/tngn |
| ThermoGenesis Corp. (NASDAQ: KOOL) | http://www.wsw.com/webcast/rrshq22/kool |
| Titan Pharmaceuticals, Inc. (OTC BB: TTNP) | http://www.wsw.com/webcast/rrshq22/ttp |
| Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) | http://www.wsw.com/webcast/rrshq22/tnxp |
| Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) | http://www.wsw.com/webcast/rrshq22/tspt |
| Verastem, Inc. (NASDAQ: VSTM) | http://www.wsw.com/webcast/rrshq22/vstm |
| Verisante Technology, Inc. (TSX: VRS CN) | http://www.wsw.com/webcast/rrshq22/vrsef |
| VirtualScopics, Inc. (NASDAQ: VSCP) | http://wsw.com/webcast/rrshq22/vscp |
| VIVUS, Inc. (NASDAQ: VVUS) | http://www.wsw.com/webcast/rrshq22/vvus |
|
Rodman & Renshaw, LLC ("Rodman") reserves the right in its sole discretion to accept or reject registration for, or admission to, all or any portion of our Conference and/or Gala Dinner. Rodman sponsors the Rodman & Renshaw Annual Global Investment Conference (the "Conference") as an informational service and networking opportunity for companies and investors. Rodman does not prepare, review or edit the presentations and other information provided by each company, and does not take any responsibility for the accuracy or adequacy of any such information as the basis for any investment decision. Rodman is not providing any person with any investment advice through their participation in or attendance of the Conference, nor is Rodman soliciting any offers to buy or sell any security of any company. Member FINRA, SIPC. |
|
© 2012 Rodman & Renshaw, LLC All rights reserved. |